Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for XNCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 -1.031M
March 31, 2026 -0.95M
December 31, 2025 -6.321M
September 30, 2025 0.00
June 30, 2025 -0.662M
March 31, 2025 -2.974M
December 31, 2024 -4.431M
September 30, 2024 -189.86M
June 30, 2024 -1.07M
March 31, 2024 -1.787M
December 31, 2023 -2.19M
September 30, 2023 -0.356M
June 30, 2023 -1.921M
March 31, 2023 -0.922M
December 31, 2022 -1.171M
September 30, 2022 -1.287M
June 30, 2022 -2.513M
March 31, 2022 -0.731M
December 31, 2021 -32.63M
September 30, 2021 -3.229M
June 30, 2021 -1.84M
March 31, 2021 -5.339M
December 31, 2020 -9.587M
September 30, 2020 -2.986M
June 30, 2020 -4.00M
Date Value
March 31, 2020 -1.471M
December 31, 2019 -2.973M
September 30, 2019 -3.049M
June 30, 2019 -3.973M
March 31, 2019 -0.667M
December 31, 2018 -1.165M
September 30, 2018 -4.153M
June 30, 2018 -2.308M
March 31, 2018 -246.62M
December 31, 2017 -0.621M
September 30, 2017 -0.99M
June 30, 2017 -1.096M
March 31, 2017 -1.026M
December 31, 2016 -119.80M
September 30, 2016 -0.501M
June 30, 2016 -0.473M
March 31, 2016 -0.20M
December 31, 2015 -0.387M
September 30, 2015 -0.114M
June 30, 2015 -0.33M
March 31, 2015 -115.55M
December 31, 2014 -0.178M
September 30, 2014 -0.001M
June 30, 2014 -0.133M
March 31, 2014 -0.004M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
UroGen Pharma Ltd. -0.9144M
MeiraGTx Holdings Plc -108.91M
Regeneron Pharmaceuticals, Inc. 1.120B
Ironwood Pharmaceuticals, Inc. -0.303M
MacroGenics, Inc. -0.173M